Anzeige
+++>>> GOLD knallt hoch! Diese Aktie sofort kaufen! <<<+++
CAREDX INC. DL-,001 WKN: A118WG ISIN: US14167L1035 Kürzel: CDNA Forum: Aktien Thema: Hauptdiskussion
14,24 EUR
±0,00 %±0,00
18. May, 13:00:51 Uhr,
Lang & Schwarz
Kommentare 94
Summer.76,
03.11.2022 21:07 Uhr
0
CareDx Reports Third Quarter 2022 Results
https://www.benzinga.com/pressreleases/22/11/b29555287/caredx-reports-third-quarter-2022-results
Summer.76,
01.11.2022 12:09 Uhr
0
https://www.businesswire.com/news/home/20221101005639/en/Independent-Longitudinal-Study-Finds-CareDx%E2%80%99s-AlloSure-Detects-Early-Signs-of-Rejection-in-Pediatric-Kidney-Transplant-Patients
abeni,
27.09.2022 13:17 Uhr
0
Transplantationspatienten erleben weniger Schmerzen und weniger unerwünschte Ereignisse mit nicht-invasiven Testlösungen von CareDx
https://www.businesswire.com/news/home/20220927005427/en/Transplant-Patients-Experience-Less-Pain-and-Fewer-Adverse-Events-with-CareDx-Non-Invasive-Testing-Solutions
Summer.76,
04.08.2022 22:34 Uhr
0
CareDx Q2 results miss estimates, co revises FY 2022 revenue guidance
https://seekingalpha.com/news/3867475-caredx-q2-results-miss-estimates-co-revises-fy-2022-revenue-guidance
• CareDx press release (NASDAQ:CDNA): Q2 Non-GAAP EPS of -$0.13 misses by $0.02.
• Revenue of $80.6M (+8.6% Y/Y) misses by $1.25M.
• Sees FY 2022 revenue of $325 million to $335 million vs. previous forecast of $330M to $350M. The consensus revenue estimate is $337.96M.
Summer.76,
04.08.2022 22:06 Uhr
0
CareDx Reports Second Quarter 2022 Results
https://www.businesswire.com/news/home/20220804005967/en/CareDx-Reports-Second-Quarter-2022-Results
Summer.76,
02.08.2022 15:36 Uhr
0
CareDx Launches Personalized AlloHome Patient Monitoring Solution to Augment Pre- and Post-Transplant Care
https://www.businesswire.com/news/home/20220802005596/en/CareDx-Launches-Personalized-AlloHome-Patient-Monitoring-Solution-to-Augment-Pre--and-Post-Transplant-Care
AlloHome Alerts Healthcare Provider of Adverse Events to Drive Earlier Interventions
Summer.76,
02.06.2022 19:15 Uhr
0
https://www.businesswire.com/news/home/20220602005408/en/CareDx-Leads-Transplant-Innovation-with-AiKidney-an-AI-Clinical-Decision-Support-Tool-for-Predicting-Allograft-Rejection-Risk
Summer.76,
24.05.2022 16:24 Uhr
0
https://www.globenewswire.com/news-release/2022/05/24/2449070/31386/en/CareDx-Receives-CE-Mark-for-AlloSeq-HCT-for-Use-in-Hematopoietic-Cell-Transplantation.html
Summer.76,
17.05.2022 16:58 Uhr
0
https://www.globenewswire.com/news-release/2022/05/17/2444754/31386/en/In-CareDx-Initiated-IP-Litigation-Against-Natera-Natera-Now-Drops-1-of-2-Patents-Originally-Asserted-Against-CareDx.html
Summer.76,
06.05.2022 5:55 Uhr
0
CareDx Reports First Quarter 2022 Results
https://www.globenewswire.com/news-release/2022/05/05/2437284/31386/en/CareDx-Reports-First-Quarter-2022-Results.html
Summer.76,
05.05.2022 15:19 Uhr
0
https://www.globenewswire.com/news-release/2022/05/05/2436571/31386/en/CareDx-Validates-Clinical-Performance-of-AlloMap-Kidney-to-Comprehensively-Assess-Transplant-Rejection.html
Summer.76,
14.04.2022 19:42 Uhr
0
https://www.globenewswire.com/news-release/2022/04/14/2422640/31386/en/CareDx-Reports-Over-200-000-Heart-Transplant-Patient-Results-Served.html
CareDx Reports Over 200,000 Heart Transplant Patient Results Served
CareDx Testing Services Have Been Used in Over 30,000 Heart Transplant Patients and Over 90 Percent of Centers in the United States
Summer.76,
11.04.2022 16:12 Uhr
0
https://www.globenewswire.com/news-release/2022/04/11/2419896/31386/en/CareDx-the-Leading-Sponsor-of-UNOS-Transplant-Management-Forum-Demonstrates-the-Value-of-Digital-Solutions-to-Improve-Pre-Transplant-Patient-Referral-and-Waitlisting-Workflow.html
Summer.76,
30.03.2022 17:52 Uhr
0
https://www.globenewswire.com/news-release/2022/03/30/2412689/31386/en/CareDx-Partners-with-the-European-Society-for-Organ-Transplantation-to-Provide-Clinical-Evidence-Supporting-the-Use-of-AlloSeq-cfDNA-with-European-Transplant-Healthcare-Professiona.html
Summer.76,
24.03.2022 20:07 Uhr
0
https://www.globenewswire.com/news-release/2022/03/24/2409242/0/en/CareDx-s-AlloCare-App-Now-Integrated-with-TxAccess-to-Help-Pre-Transplant-Patients-Navigate-the-Waitlist-Process.html
Summer.76,
15.03.2022 9:25 Uhr
0
CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; ...
https://www.bakersfield.com/ap/news/caredx-wins-44-9m-in-damages-in-false-advertising-trial-against-natera-natera-intentionally/article_8849930e-0d01-591f-b643-3ba8c4035548.html
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | GAMESTOP Hauptdiskussion | -19,62 % | |
2 | DAX Hauptdiskussion | +0,13 % | |
3 | Jaguar Health für Investierte und Interessierte | ±0,00 % | |
4 | VODAFONE Hauptdiskussion | ±0,00 % | |
5 | NEL ASA Hauptdiskussion | ±0,00 % | |
6 | AMC ENTERTAINMENT Hauptdiskussion | -4,75 % | |
7 | ARTEC Hauptdiskussion | ±0,00 % | |
8 | Börsentheater | ||
9 | Aixi sachliches Forum | ±0,00 % | |
10 | BILFINGER Hauptdiskussion | ±0,00 % | Alle Diskussionen |
Anzeige
Aktien
|
Thema | ||
---|---|---|---|
1 | GAMESTOP Hauptdiskussion | -20,31 % | |
2 | Jaguar Health für Investierte und Interessierte | ±0,00 % | |
3 | VODAFONE Hauptdiskussion | ±0,00 % | |
4 | NEL ASA Hauptdiskussion | ±0,00 % | |
5 | AMC ENTERTAINMENT Hauptdiskussion | -5,38 % | |
6 | ARTEC Hauptdiskussion | ±0,00 % | |
7 | Aixi sachliches Forum | ±0,00 % | |
8 | TRANSCANNA HOLDINGS INC. Hauptdiskussion | ±0,00 % | |
9 | Rund ums Thema , allgemeine Artikel für Leseratten. | ±0,00 % | |
10 | PLUG POWER Hauptdiskussion | +0,07 % | Alle Diskussionen |